The ratings of three medical devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Given Imaging () is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week. Given Imaging has developed a proprietary wireless imaging system that allows a medical professional to examine the gastrointestinal tract. GIVN also rates an F in Portfolio Grader’s specific subcategory of Earnings Surprise. Trade volume fell markedly in the past week, standing at half of the previous rate. The stock has a trailing PE Ratio of 58.10. .
10 Best Diversified Bank Stocks To Invest In Right Now: DARA Biosciences Inc.(DARA)
DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company?s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transpl antation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Lisa Levin]
DARA BioSciences (NASDAQ: DARA) shares fell 15.02% to touch a new 52-week low of $1.81. DARA BioSciences' trailing-twelve-month ROA is -66.74%.
LCNB (NASDAQ: LCNB) shares touched a new 52-week low of $16.57. LCNB shares have dropped 4.80% over the past 52 weeks, while the S&P 500 index has gained 18.57% in the same period.
Hot Building Product Companies To Own For 2014: Nissan Motor Co Ltd (NSANF)
NISSAN MOTOR CO., LTD. is an automobile manufacturer. The Company has two business segments. The Automobile segment is engaged in the manufacturing, trading and distribution of various types of automobiles, marine products and accessories, as well as the research, development and sale of lithium-ion secondary batteries. The Sales Financing segment is engaged in the provision of sales financing, as well as property and casualty insurance services, among others. On November 11, 2013, the Company announced that it had established an Indonesia-based subsidiary, which is engaged in the captive finance business to make loans to the customers of Indonesia. Advisors' Opinion:- [By Blake Ellis]
Industries boasting the highest percentage of companies with perfect scores include law, banking and financial services, and retail and consumer products. Companies new to the 100% club include Nissan (NSANF), General Electric (GE, Fortune 500) and Procter & Gamble (PG, Fortune 500). Other companies among the most improved this year (though they haven't achieved perfect scores yet) include Wal-Mart (WMT, Fortune 500), which saw its score jump from a 60 to 80 after it introduced same-sex benefits for employees, and Cracker Barrel (CBRL), which rose 10 points to a score of 45 after it launched a LGBT employee network and implemented a non-discrimination policy for LGBT employees.
- [By Peter Valdes-Dapena]
Nissan (NSANF) will ask owners of effected vehicles to bring their vehicles to a Nissan or Infiniti dealer to have the ABS computer chips reprogrammed. The service will be performed at no charge. No accidents or injuries have been reported due to the problem, Nissan said.
Hot Building Product Companies To Own For 2014: Amyris Inc.(AMRS)
Amyris, Inc., an integrated renewable products company, provides alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The company uses its industrial synthetic biology platform to modify microorganisms, primarily yeast, to convert plant-sourced sugars into a variety of hydrocarbon molecules that serve as flexible building blocks to be used in a range of products. It is also involved in the sale of ethanol and ethanol blended gasoline to wholesale customers through a network of terminals primarily in the southeastern Unites States. In addition, the company sells farnesene or Biofene, which is used as an ingredient in a range of consumer and industrial products, including detergents, cosmetics, perfumes, and industrial lubricants. Further, it focuses on the commercialization of renewable diesel and jet fuel. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc . in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Advisors' Opinion:- [By Maxx Chatsko]
Acknowledge the future
When thinking about biotechnology I like to encourage investors to take a big-picture approach that goes beyond pharma. Dozens of industrial biotech companies will produce commercial quantities of chemicals, fuels, fragrances, personal-care products, nutritionals, and more by the end of the decade. Two of the more promising investments currently within reach of investors are Solazyme (NASDAQ: SZYM ) and Amyris (NASDAQ: AMRS ) - [By Maxx Chatsko]
Don't forget about...
Gevo may be a promising renewable fuel partner for Uncle Sam, but it isn't the only one. Solazyme (NASDAQ: SZYM ) began extensive testing on three of its fuels -- two renewable diesels and one renewable jet fuel -- with the U.S. Navy in 2009. The company supplied 600,000 gallons of fuels between 2011 and 2012 under various programs. Similarly, Amyris (NASDAQ: AMRS ) is working with DARPA under The Living Foundries program to build a quickly scalable industrial biotechnology platform. While it could one day be used for fuels or chemicals, vaccines or nutritionals, such a breakthrough would certainly catch the eye of the petroleum-guzzling DoD. Outside of the project, the company is working toward supplying commercial quantities of renewable jet fuel with partner Total by 2014 and already supplies renewable diesel in Brazil.
Hot Building Product Companies To Own For 2014: Nu Skin Enterprises Inc.(NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, targeted treatments, total care, cosmetic, and Epoch, a product formulated with botanical ingredients. The company?s nutritional supplements product line comprises micronutrient supplements, targeted solution supplements, and weight management products. It also sells Vitameal, which are nutritious meal products for starving children or purchased for personal food storage. In addition, the company offers other products and services consisting of digital content storage, water purifiers, and other household products. It sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific. The c ompany also operates retail stores to sell its products in China. As of December 31, 2010, Nu Skin Enterprises operated 40 stores throughout China. The company was founded in 1984 and is headquartered in Provo, Utah.
Advisors' Opinion:- [By Sue Chang and Ben Eisen]
Shares of Nu Skin (NUS) � sank for a third day, losing another 6.3%. Chinese regulators are investigating allegations that the distributor of personal care products is operating an illegal pyramid scheme. In a statement, Nu Skin said it has launched its own review and plans to work with Chinese authorities to address any issues.
- [By Sue Chang and Saumya Vaishampayan]
HLF: Herbalife Ltd. (HLF) �shares added 3% and Nu Skin Enterprises Inc. (NUS) rose 3.3%. The nutrition supplement company, along with Nu Skin, were not among the companies the Federal Trade Commission charged for deceptive advertising . Hedge fund manager Bill Ackman, who has a huge short position on Herbalife, has been calling on the FTC to probe the company for irregularities. The FTC on Tuesday said Sensa will pay $26.5 million to settle charges for deceiving consumers with unproven weight-loss claims and misleading advertisements. L��ccitane and HCG Diet Direct were also charged for ��nfounded promises��of weight loss.
No comments:
Post a Comment